Adaptive Biotech To Present 2 Studies Demonstrating Utility Of Immunosequencing To Propel Diagnostic Development And Therapeutic Discovery At The 2016 American Association Of Immunologists Annual Meeting

ATTLE--(BUSINESS WIRE)--Adaptive Biotechnologies, the leader in combining next generation sequencing (NGS) and expert bioinformatics to profile T- and B-cell receptors of the adaptive immune system, will present data demonstrating how profiling the T-cell repertoire has the potential to advance diagnostic development and therapeutic discovery in immune-mediated diseases at the American Association of Immunologists (AAI) Annual Meeting in Seattle, May 13-17, 2016.